Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • AON SS. ANTONIO E BIAGIO E C. ARRIGO - SS emostasi e trombosi Alessandria, Italy
  • SOD Clinica Ematologica AOU Ospedali Riuniti Umberto I GM Lancisi G Salesi Ancona, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Policlinico S. Orsola Bologna, Italy
View all 21 locations
View Trial Details
Completed

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Bologna, Italy
  • Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi Catania, Italy
  • Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Florence, Italy
View all 13 locations
View Trial Details
Completed

A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

NCT05583838

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The Second Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
  • the Second Hospital of HeBei Medical University Shijiazhuang, Hebei, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Heibei, China
  • The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View all 17 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04188379

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010038 Tucson, Arizona, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010034 Jacksonville, Florida, United States
  • Investigator site 0010037 Ocala, Florida, United States
View all 121 locations
View Trial Details
Completed

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 110 Tucson, Arizona, United States
  • Sobi Site 119 Whittier, California, United States
  • Sobi Site 123 Washington D.C., District of Columbia, United States
  • Sobi Site 129 Miami, Florida, United States
View all 20 locations
View Trial Details
Completed

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

NCT03524612

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Hematology Oncology Association of Rockland Nyack, New York, United States
  • Case Western Reserve Cleveland, Ohio, United States
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
View all 32 locations
View Trial Details
Completed

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

NCT00621894

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of California San Diego Medical Center San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Davis, Posteraro and Wasser, MD's LLP Manchester, Connecticut, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04687072

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Springdale, Arkansas, United States
  • Investigator site 0010036 Los Angeles, California, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010104 Weston, Florida, United States
View all 200 locations
View Trial Details

Related conditions